Diversified Trust Co Reduces Stake in Medidata Solutions, Inc. (MDSO)

Diversified Trust Co cut its position in Medidata Solutions, Inc. (NASDAQ:MDSO) by 11.6% during the second quarter, Holdings Channel reports. The fund owned 4,730 shares of the company’s stock after selling 620 shares during the period. Diversified Trust Co’s holdings in Medidata Solutions were worth $370,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of the company. State of Alaska Department of Revenue raised its stake in Medidata Solutions by 2.2% in the first quarter. State of Alaska Department of Revenue now owns 6,080 shares of the company’s stock worth $350,000 after buying an additional 130 shares during the period. Everence Capital Management Inc. bought a new stake in Medidata Solutions during the first quarter worth $214,000. Conestoga Capital Advisors LLC raised its stake in Medidata Solutions by 26.3% in the first quarter. Conestoga Capital Advisors LLC now owns 614,031 shares of the company’s stock worth $35,423,000 after buying an additional 128,031 shares during the period. Louisiana State Employees Retirement System raised its stake in Medidata Solutions by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 22,300 shares of the company’s stock worth $1,286,000 after buying an additional 300 shares during the period. Finally, CrestPoint Capital Management LLC raised its stake in Medidata Solutions by 35.1% in the first quarter. CrestPoint Capital Management LLC now owns 13,100 shares of the company’s stock worth $756,000 after buying an additional 3,400 shares during the period.

Medidata Solutions, Inc. (MDSO) traded down 1.63% on Thursday, reaching $75.26. The company’s stock had a trading volume of 231,477 shares. The company has a market capitalization of $4.24 billion, a PE ratio of 127.78 and a beta of 1.81. The firm has a 50-day moving average of $77.40 and a 200-day moving average of $63.50. Medidata Solutions, Inc. has a one year low of $46.10 and a one year high of $85.92.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Tuesday, July 18th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.28 by $0.03. The business had revenue of $137.41 million during the quarter, compared to the consensus estimate of $134.28 million. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The firm’s quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.24 earnings per share. Analysts predict that Medidata Solutions, Inc. will post $1.28 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This article was originally published by [[site]] and is the property of of [[site]]. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at [[permalink]].

A number of research firms have recently weighed in on MDSO. J P Morgan Chase & Co boosted their target price on Medidata Solutions to $87.00 and gave the company an “overweight” rating in a research note on Tuesday. Citigroup Inc. reissued a “buy” rating and issued a $94.00 target price (up previously from $77.00) on shares of Medidata Solutions in a research note on Monday, July 10th. Piper Jaffray Companies boosted their target price on Medidata Solutions to $87.00 and gave the company an “overweight” rating in a research note on Friday, July 7th. SunTrust Banks, Inc. boosted their target price on Medidata Solutions from $80.00 to $90.00 and gave the company a “buy” rating in a research note on Tuesday, June 27th. Finally, BidaskClub raised Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $75.83.

In other Medidata Solutions news, EVP Michael I. Otner sold 7,500 shares of the firm’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $66.39, for a total value of $497,925.00. Following the completion of the sale, the executive vice president now owns 78,419 shares of the company’s stock, valued at $5,206,237.41. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Michael L. Capone sold 5,000 shares of the firm’s stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $69.46, for a total transaction of $347,300.00. Following the completion of the sale, the chief operating officer now directly owns 171,754 shares of the company’s stock, valued at approximately $11,930,032.84. The disclosure for this sale can be found here. In the last three months, insiders sold 18,139 shares of company stock valued at $1,259,466. 5.80% of the stock is owned by insiders.

About Medidata Solutions

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).